Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft conflicts-of-interest policy — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-010/3
Series
Public comment period
Version
1.0
Published
01 Apr 2023
Last reviewed
01 Apr 2023
Next review
01 Apr 2024
Identifier
10.71829/cei.cp.10
Certainty
Not rated
Cycle
2023 Q1
Window
26 Jan 2023 – 23 Mar 2023
Status
Closed
Submissions
12

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-CONFLICTS-PO/009Dr Rukayat Zaleski-MbekiThe Institute publishes no telephone number and no messaging channelNoted, no amendment
DRAFT-CONFLICTS-PO/010Rosalind PetrossianAn industry submission should be identifiable without reading the declared interestAccepted
DRAFT-CONFLICTS-PO/005Dr Ludmila TollemacheRecusal should follow automatically from any declared financial interestNot accepted
DRAFT-CONFLICTS-PO/003Quentin Gwynne-Sarpong industryThe document should not describe uses outside the approved indicationNot accepted
DRAFT-CONFLICTS-PO/004Dr Wolfram Kaltenbach-MensahDeclared interests should appear on the document rather than on a separate pageNoted, no amendment
DRAFT-CONFLICTS-PO/006Dr Jolyon Grünbaum-SowandeThe document is unreadable without specialist trainingAccepted in part
DRAFT-CONFLICTS-PO/011Dr Hyacinth Oyelaran-SteenThe search date is not on the face of the documentAccepted
DRAFT-CONFLICTS-PO/007Dr Dmitri NordhagenThe secretariat answers submissions and is not itself namedAccepted in part
DRAFT-CONFLICTS-PO/001Dr Ottoline Fitzgerald-NwosuThe document should state what a reader ought to doNot accepted
DRAFT-CONFLICTS-PO/012Dr Amara VandergraafPoint estimates are given without an intervalAccepted in part
DRAFT-CONFLICTS-PO/008Dr Liesbeth QuennevilleA party criticised in an assessment should have a right of replyAccepted in part
DRAFT-CONFLICTS-PO/002Dr Zebedee Zaleski-MbekiThe terms on which the documents may be reused are not statedAccepted
12 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted3The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part4Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment2The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted3The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. An industry submission should be identifiable without reading the declared interest — arising from DRAFT-CONFLICTS-PO/010. A submission made on behalf of a company is now identified as an industry submission on its face, at the head of the submission and in the disposition table, in addition to the declared interest published in full beneath it.
  2. The document is unreadable without specialist training — arising from DRAFT-CONFLICTS-PO/006. Every document now opens with a plain-language summary of not more than 150 words, placed above the technical abstract and carrying the same certainty language, so that the two cannot diverge.
  3. The search date is not on the face of the document — arising from DRAFT-CONFLICTS-PO/011. The search date is now printed adjacent to every certainty rating and is carried in the document metadata, so that the interval between the search and the reading is visible without reference to the methods section.
  4. The secretariat answers submissions and is not itself named — arising from DRAFT-CONFLICTS-PO/007. Every comment period now names the secretariat members responsible for it, with their declared interests, in the consultation front matter, so that the responses can be read against the interests of the people who wrote them.
  5. Point estimates are given without an interval — arising from DRAFT-CONFLICTS-PO/012. Every estimate now carries its interval where the source reported one, and where it did not, the estimate is annotated as reported without an interval rather than left to appear as a precise figure.
  6. A party criticised in an assessment should have a right of reply — arising from DRAFT-CONFLICTS-PO/008. A standing correction route is now published, corrections of fact are assessed and applied at any time with the change recorded in the amendment log, and a submission of substance received outside a window is held and published in the next comment period on…
  7. The terms on which the documents may be reused are not stated — arising from DRAFT-CONFLICTS-PO/002. The reuse terms are now stated explicitly on the legal page and in the document footer, permitting quotation and reproduction with attribution and the document version, and requiring that any reproduction carry the certainty rating that accompanied the quoted…

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.